The future looks bright for HCV patients who have failed to respond to current treatments

Highly anticipated data from a number of clinical trials presented for the first time at the International Liver Congress confirmed that a range of new proteases inhibitors will help treat patients who have previously failed therapy for the treatment of chronic hepatitis C.

Read the whole article on Science Daily

More from Science Daily